Safety of renal biopsy bleeding prophylaxis with desmopressin.

Background: Percutaneous renal biopsy (PRB) is invasive, and bleeding-related complications are a concern. Desmopressin (DDAVP) is a selective type 2 vasopressin receptor-agonist also used for haemostasis.

Aim: To evaluate the side effects of intravenous (IV) weight-adjusted desmopressin preceding PRB.